The use of anti-interleukin-1 agents and tumor necrosis factor‐alpha inhibitors in renal transplant recipients

OBJECTIVES: The aim of this study was to investigate the efficacy and safety of anti-interleukin-1 (anti-IL-1) agents and tumor necrosis factor‐alpha (TNF-α) inhibitors in renal transplant patients. PATIENTS AND METHODS: Between February 2014 and February 2020, data of 12 renal transplant recipients...

Descripción completa

Detalles Bibliográficos
Autores principales: Yazısız, Veli, Yılmaz, Vural Taner, Uçar, İsmail, Dandin, Özgür, Aslan, Bengisu, Erbasan, Funda, Koçak, Hüseyin, Ender Terzioğlu, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish League Against Rheumatism 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612503/
https://www.ncbi.nlm.nih.gov/pubmed/34870168
http://dx.doi.org/10.46497/ArchRheumatol.2021.8500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612503/
https://www.ncbi.nlm.nih.gov/pubmed/34870168
http://dx.doi.org/10.46497/ArchRheumatol.2021.8500

Ejemplares similares